Center for Advanced Parkinson Research

Harvard biomarkers study: Biomarkers for Parkinson's

0 Comments

/

November 4, 2018

Learn more about our Parkinson's disease biomarkers study!

Genomic ‘dark matter’ bridges gap between Parkinson’s, other neuropsychiatric disorders, study finds

0 Comments

/

October 1, 2018

Noncoding RNAs active in dopamine neurons are a surprising link between genetic risk and Parkinson's disease.

Cognitive risk score calculator

0 Comments

/

October 1, 2018

This risk assessment tool estimates the chance of a person with Parkinson's disease to develop global cognitive impairment. More information may be found at Cognitive Risk Score Calculator for Parkinson's Disease

BRAINcode: An encyclopedia of human brain cells

September 30, 2018

BRAINcode is an encyclopedia of the entire RNA content of dopamine and pyramidal neurons in the human brain. More information may be found at BRAINcode Project

Passive in-home patient monitoring: From wearables to invisibles

0 Comments

/

September 14, 2018

Dr. Dina Katabi visits the Advanced Center for Parkinson's Disease Research to present on new innovations in mobile and wireless technology with application to digital health.

Energy crisis in brain may spark Parkinson’s, CBS NEWS

Parkinson's GBA genetic study

0 Comments

/

April 3, 2018

Learn more about the Parkinson's disease study specifically targeting the GBA gene!

Investigating LRRK2 as a common genetic contributor to Parkinson's disease

0 Comments

/

October 19, 2017

Dr. Jie Shen and her team describe an essential role of LRRK in the brain during aging that may help shed light on the causes of PD.

Could repurposed asthma drugs treat Parkinson’s disease?

0 Comments

/

September 16, 2017

Team makes a surprising discovery that some asthma medicines may also hold the potential to treat or help prevent Parkinson’s disease.

New tool may help researchers predict cognitive decline with Parkinson's disease

0 Comments

/

June 23, 2017

A new tool from researchers at Harvard Medical School may allow investigators to predict cognitive decline in people with Parkinson's disease (PD), which could help design clinical trials and test new therapies. The tool uses an algorithm combining varied personal details -- age at onset, baseline score on the Mini Mental State Examination, years of education, motor exam score, sex, depression, and GBA mutation status.

Lindquist leaves behind Parkinson's interactome as her parting gift

0 Comments

/

February 11, 2017

For the many genes and proteins involved in Parkinson’s disease, it’s a small world. Basically, they are all at least friends of friends. Leveraging connections between yeast genes to infer links between human genes, researchers led by the late and beloved Susan Lindquist of the Whitehead Institute for Biomedical Research in Cambridge, Massachusetts, have just made that clear.

Clemens Scherzer, M.D.

November 14, 2016